Designer Receptors Exclusively Activated By Designer Drugs (Dreadd) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DREADD-expressing neurons are used in research to manipulate neural circuits in neurodegenerative disease models. [1]
DREADDs (Designer Receptors Exclusively Activated by Designer Drugs) are chemogenetic tools based on G-protein coupled receptors.
For researchers considering DREADDs vs. other methods:
| Method | Temporal Resolution | Spatial Precision | Invasive |
|---|---|---|---|
| DREADDs | Hours | Cell-type specific | Viral injection |
| Optogenetics | Milliseconds | Single cells | Fiber implants |
| Chemogenetics | Hours | Cell-type specific | Viral injection |
| Pharmacology | Variable | Region-wide | None |
DREADDs are primarily research tools. Similar chemogenetic approaches may eventually translate to clinical applications via AAV gene therapy.
DREADDs exploit the muscarinic acetylcholine receptor signaling pathway:
hM3Dq (Gq-DREADD): Activates Gq proteins, leading to phospholipase C (PLC) activation, IP3 production, and calcium release from intracellular stores. This results in neuronal excitation.
hM4Di (Gi-DREADD): Inhibits adenylate cyclase, reducing cAMP production and hyperpolarizing neurons through GIRK channels.
Custom variants: Modified versions like hM4Di-Kir2.1 provide enhanced inhibitory effects through direct potassium channel coupling.
The most commonly used DREADD ligand is clozapine N-oxide (CNO), which is the active metabolite of clozapine. However, recent studies have identified more selective compounds:
| Compound | Affinity | Selectivity | Notes |
|---|---|---|---|
| CNO | High | Moderate | Classic ligand, back-metabolizes to clozapine |
| Compound 21 (C21) | High | High | Improved selectivity |
| Deschloroclozapine (DCZ) | Very High | Very High | Recent development |
DREADDs are widely used for mapping neural circuits:
The temporal resolution of DREADD manipulation:
For researchers considering DREADDs vs. other methods:
| Method | Temporal Resolution | Spatial Precision | Invasive |
|---|---|---|---|
| DREADDs | Hours | Cell-type specific | Viral injection |
| Optogenetics | Milliseconds | Single cells | Fiber implants |
| Chemogenetics | Hours | Cell-type specific | Viral injection |
| Pharmacology | Variable | Region-wide | None |
The study of Designer Receptors Exclusively Activated By Designer Drugs (Dreadd) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.